GlucoSet
GlucoSet is dedicated to improving patient care and reducing ICU costs through innovative glucose monitoring technology. Their minimally invasive, reliable, and easy-to-adopt sensors aim to solve the longstanding problem of continuous glucose monitoring in the ICU, with a focus on low-cost mass production and strong intellectual property protection.
Industries
Nr. of Employees
small (1-50)
GlucoSet
Patents
Products
Arterial catheter-based continuous blood glucose monitoring system
A minimally invasive monitoring system that measures blood glucose continuously via a sensor introduced through an existing arterial catheter; designed for ICU use with rapid nurse-led setup and robustness to common ICU interferences.
Arterial catheter-based continuous blood glucose monitoring system
A minimally invasive monitoring system that measures blood glucose continuously via a sensor introduced through an existing arterial catheter; designed for ICU use with rapid nurse-led setup and robustness to common ICU interferences.
Expertise Areas
- Continuous glucose monitoring for critical care
- Catheter-based sensor integration
- Miniaturized medical sensor design
- Device validation in ICU environments
Key Technologies
- Arterial catheter-based sensing
- Continuous blood glucose monitoring
- Miniaturized implantable sensor design
- Robust signal acquisition in presence of physiological interferences
News & Updates
GlucoSet received funding from the European Union’s Horizon Europe Research and Innovation program.
GlucoSet received funding from the Norwegian Research Council.
GlucoSet received funding from the European Union’s Horizon Europe Research and Innovation program.
GlucoSet received funding from the Norwegian Research Council.